JP2015083580A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015083580A5 JP2015083580A5 JP2014245645A JP2014245645A JP2015083580A5 JP 2015083580 A5 JP2015083580 A5 JP 2015083580A5 JP 2014245645 A JP2014245645 A JP 2014245645A JP 2014245645 A JP2014245645 A JP 2014245645A JP 2015083580 A5 JP2015083580 A5 JP 2015083580A5
- Authority
- JP
- Japan
- Prior art keywords
- constipation
- pharmaceutical
- medicament
- functional
- glucopyranosyloxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014245645A JP6105546B2 (ja) | 2012-05-07 | 2014-12-04 | ピラゾール誘導体及びその医薬用途 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012105847 | 2012-05-07 | ||
| JP2012105847 | 2012-05-07 | ||
| JP2014245645A JP6105546B2 (ja) | 2012-05-07 | 2014-12-04 | ピラゾール誘導体及びその医薬用途 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014514708A Division JP5663699B2 (ja) | 2012-05-07 | 2013-05-02 | ピラゾール誘導体及びその医薬用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015083580A JP2015083580A (ja) | 2015-04-30 |
| JP2015083580A5 true JP2015083580A5 (enExample) | 2016-06-16 |
| JP6105546B2 JP6105546B2 (ja) | 2017-03-29 |
Family
ID=49550709
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014514708A Active JP5663699B2 (ja) | 2012-05-07 | 2013-05-02 | ピラゾール誘導体及びその医薬用途 |
| JP2014245645A Active JP6105546B2 (ja) | 2012-05-07 | 2014-12-04 | ピラゾール誘導体及びその医薬用途 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014514708A Active JP5663699B2 (ja) | 2012-05-07 | 2013-05-02 | ピラゾール誘導体及びその医薬用途 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US9273085B2 (enExample) |
| EP (1) | EP2848254B1 (enExample) |
| JP (2) | JP5663699B2 (enExample) |
| KR (1) | KR101868991B1 (enExample) |
| CN (1) | CN104284665B (enExample) |
| AU (1) | AU2013258566B2 (enExample) |
| BR (1) | BR112014027841B1 (enExample) |
| CA (1) | CA2872002C (enExample) |
| DK (1) | DK2848254T3 (enExample) |
| ES (1) | ES2601127T3 (enExample) |
| MX (1) | MX359988B (enExample) |
| PL (1) | PL2848254T3 (enExample) |
| PT (1) | PT2848254T (enExample) |
| RU (1) | RU2602739C2 (enExample) |
| WO (1) | WO2013168671A1 (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3400944B1 (en) | 2010-11-04 | 2020-07-15 | Albireo AB | Ibat inhibitors for the treatment of liver diseases |
| CA2872002C (en) * | 2012-05-07 | 2019-01-15 | Masayuki Isaji | Pyrazole derivative and use thereof for medical purposes |
| RU2648467C2 (ru) | 2013-02-04 | 2018-03-26 | Тайсо Фармасьютикал Ко., Лтд. | Профилактическое или терапевтическое лекарственное средство для лечения запора |
| JP6751020B2 (ja) | 2014-06-25 | 2020-09-02 | Ｅａファーマ株式会社 | 固形製剤及びその着色防止又は着色低減方法 |
| CN106573033A (zh) * | 2014-06-25 | 2017-04-19 | Ea制药株式会社 | 固体制剂及其稳定化方法 |
| MX2020009349A (es) | 2018-03-28 | 2021-04-28 | Avolynt | Método para el tratamiento de la hipoglucemia posprandial. |
| TW202015699A (zh) | 2018-06-05 | 2020-05-01 | 瑞典商艾爾比瑞歐公司 | 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽汁酸調節劑之用途 |
| SG11202012170PA (en) | 2018-06-20 | 2021-01-28 | Albireo Ab | Pharmaceutical formulation of odevixibat |
| US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
| US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
| US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| EP3921028B1 (en) | 2019-02-06 | 2022-11-09 | Albireo AB | Benzothiadiazepine compounds and their use as bile acid modulators |
| US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
| PE20230234A1 (es) | 2019-12-04 | 2023-02-07 | Albireo Ab | Compuestos de benzoti(di)azepina y su uso como moduladores del acido biliar |
| US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
| CN114761018B (zh) | 2019-12-04 | 2025-12-02 | 阿尔比里奥公司 | 苯并硫杂二氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| EP4069361B1 (en) | 2019-12-04 | 2024-01-03 | Albireo AB | Benzothia(di)azepine compounds and their use as bile acid modulators |
| JP7696898B2 (ja) | 2019-12-04 | 2025-06-23 | アルビレオ・アクチボラグ | ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| JP7748451B2 (ja) | 2020-08-03 | 2025-10-02 | アルビレオ・アクチボラグ | ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| EP4243831A1 (en) | 2020-11-12 | 2023-09-20 | Albireo AB | Odevixibat for treating progressive familial intrahepatic cholestasis (pfic) |
| CA3198216A1 (en) | 2020-12-04 | 2022-06-09 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| TW202313579A (zh) | 2021-06-03 | 2023-04-01 | 瑞典商艾爾比瑞歐公司 | 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004137245A (ja) | 2002-08-23 | 2004-05-13 | Kissei Pharmaceut Co Ltd | ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体 |
| TW200801012A (en) * | 2006-04-26 | 2008-01-01 | Piramed Ltd | Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| NZ586336A (en) | 2007-12-27 | 2011-06-30 | Kissei Pharmaceutical | Monosebacate of pyrazole derivative |
| US8354382B2 (en) | 2008-04-16 | 2013-01-15 | Kissei Pharmaceutical Co., Ltd. | Hemifumarate of a pyrazole derivative |
| AR087701A1 (es) | 2011-08-31 | 2014-04-09 | Japan Tobacco Inc | Derivados de pirazol con actividad inhibidora de sglt1 |
| CA2872002C (en) * | 2012-05-07 | 2019-01-15 | Masayuki Isaji | Pyrazole derivative and use thereof for medical purposes |
-
2013
- 2013-05-02 CA CA2872002A patent/CA2872002C/en active Active
- 2013-05-02 DK DK13787714.8T patent/DK2848254T3/en active
- 2013-05-02 MX MX2014013696A patent/MX359988B/es active IP Right Grant
- 2013-05-02 JP JP2014514708A patent/JP5663699B2/ja active Active
- 2013-05-02 US US14/399,093 patent/US9273085B2/en active Active
- 2013-05-02 ES ES13787714.8T patent/ES2601127T3/es active Active
- 2013-05-02 EP EP13787714.8A patent/EP2848254B1/en active Active
- 2013-05-02 RU RU2014149181/15A patent/RU2602739C2/ru active
- 2013-05-02 WO PCT/JP2013/062755 patent/WO2013168671A1/ja not_active Ceased
- 2013-05-02 BR BR112014027841-5A patent/BR112014027841B1/pt active IP Right Grant
- 2013-05-02 PT PT137877148T patent/PT2848254T/pt unknown
- 2013-05-02 AU AU2013258566A patent/AU2013258566B2/en active Active
- 2013-05-02 CN CN201380024202.3A patent/CN104284665B/zh active Active
- 2013-05-02 PL PL13787714T patent/PL2848254T3/pl unknown
- 2013-05-02 KR KR1020147033887A patent/KR101868991B1/ko active Active
-
2014
- 2014-12-04 JP JP2014245645A patent/JP6105546B2/ja active Active
-
2016
- 2016-01-14 US US14/995,489 patent/US9694027B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015083580A5 (enExample) | ||
| ES2601127T3 (es) | Derivado de pirazol y su uso con fines médicos | |
| JP2015523407A5 (enExample) | ||
| CN105636951A (zh) | 酰胺类衍生物及其可药用盐、其制备方法及其在医药上的应用 | |
| JP2015057451A5 (enExample) | ||
| CN110036005A (zh) | 酰胺衍生物及其在药物中的应用 | |
| NZ780890A (en) | Pharmaceutical compositions comprising meloxicam | |
| JP2016106150A5 (enExample) | ||
| JP2012193216A5 (enExample) | ||
| BR112014012815A2 (pt) | derivados de trifluormetil-oxadiazol e uso dos mesmos no tratamento de doença | |
| JP2018537507A5 (enExample) | ||
| JP2014198723A5 (enExample) | ||
| CN111902417A (zh) | 一种二芳基巨环化合物、药物组合物以及其用途 | |
| JP2017014206A5 (enExample) | ||
| RU2014141893A (ru) | Применение производной пиразола в лечении острых приступов хронической обструктивной болезни легких | |
| JP2012517449A5 (enExample) | ||
| JP2019535760A5 (ja) | ガボキサドールを用いた注意欠陥多動性障害（ａｄｈｄ）の治療方法 | |
| JP2013166781A5 (enExample) | ||
| JP2020529995A5 (enExample) | ||
| JP2019218379A5 (enExample) | ||
| JP2018531273A5 (enExample) | ||
| RU2018126158A (ru) | Применение триацетил-3-гидроксифениладенозина для получения фармацевтического лекарственного средства для предупреждения или лечения неалкогольной жировой болезни печени | |
| JP2016538288A5 (enExample) | ||
| JP2013032308A5 (enExample) | ||
| CN111565708A (zh) | 一种稳定的含有非甾体抗炎药衍生物的药物组合物 |